2m 2m 2m 2m 2m 2m 2m
ANAPTYSBIO (ANAB)
NASDAQ
$57.75+$0.010 (+0.02%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.7BMarket Cap
- 185.56%1-Year Change
- BiotechnologyIndustry
ANAPTYSBIO (ANAB)
$57.75+$0.010 (+0.02%)
ANAB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $57.74 | ||
Change | +$1.05 (+1.85%) | ||
Open | $57.23 | ||
High | $58.78 | ||
Low | $56.62 | ||
Previous Close | $56.69 | ||
Volume | 318,373 | ||
30-Day Average Volume | 446,429 | ||
1-Week Change | -1.25% | ||
1-Month Change | 7.40% | ||
1-Year Change | 185.56% | ||
3-Year Change | 187.69% | ||
5-Year Change | 138.30% | ||
Fundamentals | |||
Shares Outstanding | 29.6M | ||
Total Assets | $329.7M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | $25.6M | ||
Net Income | -$52.9M | ||
Free Cash Flow | -$25.9M | ||
EBIT | -$52.8M | ||
EBITDA | -$52.7M | ||
Net Working Capital | $274.4M | ||
EPS | -$1.84 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | 57 | ||
P/B | 134 | ||
P/E | -31 | ||
PEG | 0 | ||
Price/Free Cash Flow | -66 | ||
Price/Operating Cash Flow | -66 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue